Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Dalla Costa, Elis R ^a,b   Ribeiro, Marta O ^a   Silva, Márcia Sn ^a,c   Arnold, Liane S ^a   Rostirolla, Diana C ^a   Cafrune, Patricia I ^a,d   Espinoza, Roger C ^e   Palaci, Moises ^f   Telles, Maria A ^g   Ritacco, Viviana ^h   Suffys, Philip N ^j   Lopes, Maria L ^k   Campelo, Creuza L ^l   Miranda, Silvana S ^o   Kremer, Kristin ^m   Da Silva, Pedro E Almeida ⁿ   Fonseca, Leila De Souza ^b   Ho, John L ⁱ   Kritski, Afrǎnio L ^b   Rossetti, Maria Lr ^a,c,p  

^a Rio Grande do Sul   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Luterana University of Brazil   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e LCB   (Peru)

^f FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^g INSTITUTO ADOLFO LUTZ   (Brazil)

^h Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

ⁱ Department of Obstetrics Gynecology   (United States)

^j INSTITUTO OSWALDO CRUZ   (Brazil)

^k INSTITUTO EVANDRO CHAGAS   (Brazil)

^l LACEN Cea   (Brazil)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^o FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^p Fundacao Estadual de Producao e Pesquisa em Saude FEPPS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KATG PROTEIN;

AHPC GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL EVALUATION; DISEASE TRANSMISSION; GENE LOCUS; GENE MUTATION; HEALTH PROGRAM; IN VITRO STUDY; INFECTION CONTROL; INHA GENE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYR GENE; PREVALENCE; SOUTH AMERICA; STRUCTURAL GENE; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 78650421645     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-39     Document Type: Article

References (50)

1. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. SVJ Ramaswamy MJ Musser, Tubercle Lung Dis 1998 79 1 3 29 10.1054/tuld.1998.0002
2. Global tuberculosis control: surveillance, planning, financing. World Health Organization, WHO report, Geneva
3. Isoniazid resistance and the future of drug-resistant tuberculosis Microb Drug Resist. T Cohen MC Becerra MB Murray, Microb Drug Resist 2004 10 4 280 285 15650371 10.1089/mdr.2004.10.280
4. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. A Banerjee E Dubnau A Quemard V Balasubramanian KS Um T Wilson D Collins G Lisle JR Jacobs, Science 1994 263 227 230 10.1126/science.8284673 8284673
5. Epidemiologia da TB no Brasil. BRASIL, 2004. Ministério da Saúde. Secretaria de Vigilncia em Sade. Vigilncia Epidemiolágica. Tuberculose. Dados e indicadores, Disponível em http://portal.saude.gov. br/saude
6. Secretaria de Vigilncia em Saúde. BRASIL, 2006. Ministério da Saúde, CRPHF
7. Evaluacián del Programa nacional de control de la Tuberculosis en el Per-Ão 1999 y 2000. Ministerio de Salud, LIMA 1999-2000 Informes anuales 2002
8. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. JR Glynn J Whiteley PJ Bifani, Emerg Infect Dis 2002 8 843 849 12141971
9. Mycobaterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. NTN Lan HTK Lien LB Tung MW Borgdorff K Kremer D van Soolingen, Emerg Infect Dis 2003 9 12 1633 1635 14720411
10. Tuberculosis trends. Vietnam. M Vree DD Bui NS Dinh VC Nguyen MVV Borgdorff FG Cobelens, Emerg Infect Dis 2007 13 5 796 797 18044050
11. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis, Emerg Infect Dis 2006 12 736 743 16704829
12. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. BJ Marais TC Victor AC Hesseling M Barnard A Jordaan W Brittle H Reuter N Beyers PD van Helden RM Warren HS Schaaf, J Clin Microbiol 2006 44 10 3539 43 16928967 10.1128/JCM.01291-06
13. Association of specific mutations in kat G, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. MY Lipin VN Stepanshina IG Shemyakin TM Shinnick, Clin Microbiol Infect 2007 13 6 620 6 10.1111/j.1469-0691.2007.01711.x 17403134
14. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. G Middlebrook ML Cohn, Science 1953 118 297 299 10.1126/science.118.3063.297 13089681
15. Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China. M Zhang J Yue Y Yang H Zhang J Lei R Jin X Zhang H Wang, J Clin Microbiol 2005 43 5477 5482 16272473 10.1128/JCM.43.11.5477-5482.2005
16. Compensatory ahp C gene expression in isoniazid-resistant Mycobacterium tuberculosis. DR Sherman K Mdluli MJ Hickey TM Arain SL Morris CE Barry CK Stover, Science 1996 272 1641 1643 10.1126/science.272.5268.1641 8658136
17. A Ser315Thr substitution in Kat G is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St Petersburg area in Russia. HJ Marttila H Soini E Eerola E Vyshnevskaya BI Vyshnevskiy TF Otten AV Vasilyef MK Viljanen, Antimicrob Agents Chemother 1998 42 2443 2445 9736581
18. Mutations at amino acid position 315 of the kat G gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. D van Soolingen PE de Haas HR van Doorn E Kuijper H Rinder MW Borgdorff, J Infect Dis 2000 182 1788 1790 10.1086/317598 11069256
19. Effect of kat G Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans. AS Pym B Saint-Joanis ST Cole, Infection and Immunity 2002 70 4955 4960 10.1128/IAI.70.9.4955-4960.2002
20. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. HR van Doorn PEW de Haas K Kremer CMJ Vandenbroucke-Grauls MW Borgdorff D van Soolingen, Clin Microbiol Infect 2006 12 769 775 16842572
21. Mycobacterium tuberculosis complex genetic diver sity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. K Brudey JR Driscoll L Rigouts WM Prodinger A Gori SA Al-Hajoj C Allix L Aristimuno, BMC Microbiol 2006 6 23 16519816 10.1186/1471-2180-6-23
22. Contribution of AGC to ACC and other mutations at codon 315 of the kat G gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. S Ahmad E Mokaddas, Int J Antimicrob Agents 2004 23 473 479 10.1016/j.ijantimicag.2003.10.004 15120726
23. Mutations in kat G, InhA, and ahpC Genes of Brazilian Isoniazid-Resistant Isolates of Mycobacterium tuberculosis. MSN Silva S Senna MO Ribeiro AM Valim MA Telles AL Kritski GP Morlock RC Cooksey A Zaha MLR Rossetti, Journal Clin Microbiol 2003 41 9 4471 4474 10.1128/JCM.41.9.4471-4474.2003
24. Site directed mutagenesis of the kat G gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities isoniazid resistance. DA Rouse JA DeVito Z Li H Byer SL Morris, Mol Microbiol 1996 22 583 592 10.1046/j.1365-2958.1996.00133.x 8939440
25. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. RF Cardoso RC Cooksey GP Morlock P Barco L Cecon F Forestiero CQF Leite DN Sato ML Shikama EM Mamizuka MH Hirata, Antimicrob Agents Chemother 2004 48 3378 3381 10.1128/AAC.48.9.3373- 3381.2004
26. Analysis of ahp C gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. CL Kelly DA Rouse SL Morris, Agents Chemother 1997 41 9 2057 2058
27. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. ASG Lee ASM Teo SY Wong, Antimicrob Agentes Chemother 2001 45 2157 2159 10.1128/AAC.45.7.2157-2159.2001
28. XDR Tuberculosis - Implications for Global Public Health. MC Raviglione IM Smith, New Engl J Med 2007 356 7 356 359 17301295 10.1056/NEJMp068273
29. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. V Srinivas SV Ramaswamy R Reich SJ Dou L Jasperse X Pan A Wanger T Quitugua EA Graviss, Antimicrob Agents Chemother 2003 47 1241 1250 12654653 10.1128/AAC.47.4.1241-1250.2003
30. Genomic mutations in the kat G, inhA and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. PK Kiepiela KS Bishop AN Smith L Roux DF York, Tuberc Lung Dis 2000 80 47 56 10.1054/tuld.1999.0231
31. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. SY Kim YJ Park WI Kim SH Lee CL Chang SJ Kang CS Kang, Diagn Microbiol Infect Dis 2003 47 497 502 10.1016/S0732-8893(03) 00132-9 14596968
32. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. C Lavender M Globan A Sievers H Billman-Jacobe J Fyfe, Antimicrob Agents Chemother 2005 49 4068 4074 16189082 10.1128/AAC.49.10.4068-4074.2005
33. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela. L Artismun; R Armengol A Cebollada E Mercedes A Guilarte C Lafoz MA Lezcano MJ Revillo C Martín C Ramírez N Rastogi J Rojas AV Salas C Sola S Samper, BMC Microbiology 2006 6 90 17032442 10.1186/1471-2180-6-90
34. First insight into Mycobacterium tuberculosis genetic diversity in Paraguay. N Candia B Lopez T Zozio M Carrivale C Diaz G Russomando NJ de Romero JC Jar L Barrera N Rastogi V Ritacco, BMC Microbiology 2007 7 75 17686181 10.1186/1471-2180-7-75
35. Tuberculosis due to resistant Haarlem strain, Tunisia. H Mardassi A Namouchi R Haltiti, Emerg Infect Dis 2005 11 957 961 15963297
36. Global distribution of Mycobacterium tuberculosis spoligotypes. I Filliol JR Driscoll D van Soolingen BN Kreiswirth K Kremer G Valetudie, Emerg Infect Dis 2002 8 1347 9 12453368
37. Mutations in DNA repair genes are associated with the Haarlem lineage of Mycobacterium tuberculosis independently of their antibiotic resistance. J Olano B Lápez A Reyes M Del Pilar Lemos N Correa P Del Portillo L Barrea J Robledo V Ritacco MM Zambrano, Tuberculosis (Edinb) 2007 87 6 502 8 10.1016/j.tube.2007.05.011 17919978
38. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. ME Rad P Bifani C Martin K Kremer S Samper J Rauzier B Kreiswirth J Blazquez M Jouan D van Soolingen B Gicquel, Emerg Infect Dis 2003 9 838 845 12890325
39. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. V Ritacco M Di Lonardo A Reniero M Ambroggi L Barrera A Dambrosi B Lopez N Isola IN de Kantor, J Infect Dis 1997 176 637 42 9291309
40. Multidrug-resistant tuberculosis microepidemic caused by genetically closely related Mycobacterium tuberculosis strains. M Kubin M Havelkova I Hynccicova Z Svecova J Kaustova KA Kremer, J Clin Microbiol 1999 37 2715 6 10405429
41. Mycobacterium tuberculosis isolates of Beijing genotype in Thailand. WM Prodinger P Bunyaratvej R Prachaktam M Pavlic, Emerg Infect Dis 2001 7 483 4 11384540
42. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. L Qian JD Van Embden AG Van Der Zanden EF Weltevreden H Duanmu JT Douglas, J Clin Microbiol 1999 37 471 4 9889247
43. First description of Mycobacterium tuberculosis Beijing genotype in Argentina. N Morcillo B Di Giulio C Chirico A Kuriger A Dolmann A Alito M Zumarraga D van Soolingen K Kremer A Cataldi, Rev Argent Microbiol 2005 37 92 95 16178465
44. Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America. V Ritacco B Lápez PI Cafrune L Ferrazoli PN Suffys N Candia L Vsquez T Realpe T Fernndez KV Lima J Zurita J Robledo L Rossetti MA Telles AL Kritski JC Palomino H Heersma D van Soolingen K Kremer LE Barrera, Mem Inst Oswaldo Cruz 2008 103 489 492 10.1590/S0074-02762008000500014 18797764
45. Tuberculosis bacteriology organization and practice. C Collins HJM Grange MD Yates, Public health mycobacteriology: A guide for a level III laboratory Oxford, UK: Butterworth-Heinemann; Atlanta, GA, USA: Centers for Disease Control, Kent PT, Kubica GP, 2 1985
46. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. GW Canetti A Fox HT Khomenko NK Mahler DA Menon N Mitchison N Rist NA Smeley, Bull WHO 1969 41 21 43 5309084
47. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. E Montoro D Lemus M Echemendia A Martin F Portaels JC Palomino, J of Antimicrobial Chemotherapy 2005 55 500 505 10.1093/jac/dki023
48. Strain Identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. JDA Van Embden MD Cave JD Crawford JW Dale KD Eisenach B Gicquel WM Hermans C Martin R Mcadam MT Shinnick PM Small, J Clin Microbiol 1993 31 406 409 8381814
49. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Kamerbeek L Schouls A Kolk M van Agterveld D van Soolingen S Kuijper A Bunschoten H Molhuizen R Shaw M Goyal J van Embden, J Clin Microbiol 1997 35 907 914 9157152
50. Double-repetitive-element PCR method for subtyping M. tuberculosis clinical isolates. CR Friedman MY Stoeckle WD Johnson LW Riley, J Clin Microbiol 1995 33 1383 1384 7615762